The Medicines Management team at the West Lancashire Clinical Commissioning Group (CCG) provides specialist advice and information to management, staff and patients in relation to the use of medicines to ensure patients receive safe and effective drug treatment and all medicines are handled safely.
The team works as integral members of multi-professional teams and groups to ensure safe, high quality and cost-effective use of medicines to optimise outcomes for patient care.
Antimicrobial Stewardship
Resources for care homes
Resources for healthcare professionals
Rebate schemes
| Product | Generic | Start Date | End Date/Term | PrescQIPP Aligned |
| Lixiana | Edoxaban | Commercially sensitive information and therefore, exempt from FOI | Yes | |
| Clenil | Beclometasone Dipropionate | 01/06/2021 | 2 Years | Yes |
| Sereflo | Fluticasone / Salmeterol | Commercially sensitive information and therefore, exempt from FOI | Yes | |
| Fostair pMDI | Beclometasone / Formoterol | 01/08/2021 | 2 Years | Yes |
| Mezolar Matrix | Fentanyl | 31/03/2022 | Yes | |
| Xarelto | Rivaroxaban | 31/03/2024 | Yes | |
| Toujeo | Insulin Glargine | 01/10/2020 | 31/092022 | Yes |